financetom
Business
financetom
/
Business
/
Jamf Joins Okta Elevate Partner Program
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Jamf Joins Okta Elevate Partner Program
Aug 23, 2024 10:37 PM

10:43 AM EDT, 08/22/2024 (MT Newswires) -- Jamf ( JAMF ) said Thursday it has joined the Okta ( OKTA ) Elevate Partner Program to help better co-sell and co-market their technologies to their joint Apple ( AAPL ) customers.

Okta Elevate helps firms earn more rewards, retain more customers and grow market footprint, among other features.

Okta ( OKTA ) shares were up 1.4% in recent trading, while Jamf ( JAMF ) rose 0.4%.

Price: 18.49, Change: +0.07, Percent Change: +0.38

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Carlyle Group-Backed Crescent Midstream Said to Be Exploring Sale
Market Chatter: Carlyle Group-Backed Crescent Midstream Said to Be Exploring Sale
Apr 22, 2024
02:30 PM EDT, 04/22/2024 (MT Newswires) -- Crescent Midstream, an oil pipeline backed by Carlyle Group ( CG ) , is exploring a potential sale after receiving takeover interest, Bloomberg reported Monday, citing people with knowledge of the matter. (Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but...
US Supreme Court Declines To Hear Vanda Pharmaceuticals' Case Regarding Invalidation Of Patents For Its Sleep Disorder Drug, Hetlioz
US Supreme Court Declines To Hear Vanda Pharmaceuticals' Case Regarding Invalidation Of Patents For Its Sleep Disorder Drug, Hetlioz
Apr 22, 2024
The U.S. Supreme Court has reportedly chosen not to review Vanda Pharmaceuticals Inc’s attempt to revive patents for its sleep-disorder medication Hetlioz, which had previously been invalidated in a legal battle with generic drugmakers Teva Pharmaceutical Industries Limited and Apotex.  Vanda had filed a lawsuit in 2018 against Teva and Apotex in Delaware, alleging patent infringement after they sought approval to manufacture generic versions of Hetlioz, Reuters...
Western Alliance Stock Rises On Q1 Earnings Beat: Analyst Sees 'Above Peer Upside Potential'
Western Alliance Stock Rises On Q1 Earnings Beat: Analyst Sees 'Above Peer Upside Potential'
Apr 22, 2024
Western Alliance Bancorp ( WAL ) investors have been rejoicing with the stock up 3% since the company delivered an earnings beat. The bank delivered a 3.61% surprise on EPS and a 4.56% surprise on revenue, as it reported Q1 numbers on April 18 after market close. Also Read: Financial Stocks Fall After Earnings, Major Banks Notch 4-Day Losing Streak:...
Update: Market Chatter: Carlyle Group-Backed Crescent Midstream Said to Be Exploring Sale
Update: Market Chatter: Carlyle Group-Backed Crescent Midstream Said to Be Exploring Sale
Apr 22, 2024
03:01 PM EDT, 04/22/2024 (MT Newswires) -- (Updates with additional details and attempts to reach out for comments.) Crescent Midstream, an oil pipeline backed by Carlyle Group ( CG ) , is exploring a potential sale after receiving takeover interest, Bloomberg reported Monday, citing people with knowledge of the matter. The company is working with an adviser on options, the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved